ANGELINA NEIBERGER: Open Payments
NPI 1386359107 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,363 in 164 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $411 · 2025 $3,363
Food & beverage: $3,363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $697 |
| Teva Pharmaceuticals USA, Inc. | 18 | $381 |
| Vanda Pharmaceuticals Inc. | 13 | $361 |
| Axsome Therapeutics, Inc. | 15 | $345 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $272 |
| Alkermes, Inc. | 10 | $218 |
| Janssen Pharmaceuticals, Inc | 5 | $197 |
| Otsuka America Pharmaceutical, Inc. | 14 | $188 |
| Neurocrine BioSciences, Inc. | 7 | $140 |
| Bausch Health US, LLC | 7 | $123 |
Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, UZEDY, SPRAVATO, ARISTADA, HETLIOZ.
Industry payments across NC — which companies pay providers there.
